微缺失微重复综合征在特发性男性不育中富集
该回顾性研究基于504例特发性低精子总数男性的全外显子组测序数据,发现1.8%携带已知致病性微缺失/微重复,为一般人群的约2.5倍(P=0.01)。16p11.2重排者均伴隐睾,提示其可能影响睾丸发育。
要点
- 特发性低精子总数男性中约2%携带致病性微缺失/微重复。
- 16p11.2重排与隐睾相关,提示影响睾丸发育。
- 微重复携带者中3例实现生物学父亲身份,微缺失者无。
核心结论
- 特发性男性不育中约2%存在已知致病性微缺失/微重复,患病率约为一般人群的2.5倍。
研究设计与样本
- 回顾性研究纳入504例不明原因低精子总数(≤39×10^6/射精)男性,基于全外显子组测序数据检测>500 kb的拷贝数变异。
主要发现
- 9例(1.8%)携带与临床明确综合征相关的微缺失/微重复,包括16p11.2缺失2例、22q11.21重复3例等。
- 不育男性中微缺失微重复综合征总负荷为一般人群的约2.5倍(P=0.01,χ2检验)。
- 所有16p11.2重排个体均伴隐睾,为新的共有特征。
- 3例微重复携带者(无微缺失者)已实现生物学父亲身份。
- 一例16p11.2重复的少精子症患者(精子总数1.92×10^6/射精)年轻时自然生育一子。
关键数值与推荐
- 低精子总数定义为精子总数≤39×10^6/射精。
- 仅保留>500 kb的高置信度拷贝数变异。
- 22q11.21重复两例(精子总数分别为0和4.2×10^6/射精)经ART-ICSI(伴或不伴睾丸取精)成功受孕分娩。
临床怎么用
- 对特发性低精子总数男性可考虑微缺失微重复检测,阳性结果有助于遗传咨询及ART决策。
局限性
- 全外显子组测序可能漏检倒位或平衡易位等结构变异。
- 部分微缺失/微重复仅见于单例,与男性不育的关联无法明确。
- 3p25.1微重复对精子发生的影响需进一步数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the impact of undiagnosed microdeletion and microduplication syndromes (MMS) for men with idiopathic low sperm count? SUMMARY ANSWER: Among idiopathic male infertility, ∼2% of cases harbour known disease-causing microdeletions and duplications linked to clinically well-established syndromes, representing ∼2.5-fold higher prevalence than in the general population. WHAT IS KNOWN ALREADY: While infertility affects up to 10% of men, a substantial proportion of cases remain with no identifiable underlying cause. Recurrent submicroscopic losses or gains cause MMS, some of which also impact reproductive phenotypes, including cryptorchidism and reduced fertility. STUDY DESIGN, SIZE, DURATION: This retrospective study investigated the proportion of undiagnosed MMS among idiopathic male infertility cases. Patients with unexplained low total sperm counts (TSC; defined as ≤39 million sperm per ejaculate) were recruited to the ESTonian ANDrology (ESTAND) cohort at the Andrology Clinic of Tartu University Hospital (AC-TUH) in Estonia. A total of 504 men were included in the analysis, and the study capitalized on available whole-exome sequencing (WES) data to explore large (>500 kb) chromosomal deletions and duplications. PARTICIPANTS/MATERIALS, SETTING, METHODS: Copy number variant (CNV) calling was executed on the WES dataset, followed by a stringent, custom-developed filtering pipeline that retained only high-confidence CNVs larger than 500 kb. Candidate CNVs were validated by chromosomal microarray analysis (CMA) or whole-genome sequencing (WGS). Prevalence of identified MMS-linked deletions and duplications in the ESTAND cohort was compared to general population literature data. MAIN RESULTS AND THE ROLE OF CHANCE: A total of nine patients (1.8%) carried losses and gains linked to clinically well-characterized MMS-recurrent microdeletions at 16p11.2 (two cases), 2q13-14.1, and 15q13.2-13.3, and microduplications at 22q11.21 (three cases), 16p11.2, and 8p23.1. The total burden of MMS among infertile men was ∼2.5-fold higher compared to the general population (P = 0.01, χ2 test). Cryptorchidism was a novel shared feature among all individuals with 16p11.2 rearrangements, suggesting a potential role in disrupting testicular development. Three subjects with MMS-linked microduplications, but none with a microdeletion, had achieved biological fatherhood. An oligozoospermia case (TSC 1.92 × 106/ej.) with 16p11.2 duplication had a naturally conceived child in youthhood. For two men carrying 22q11.21 duplication (TSC 0 and 4.2 × 106/ej., respectively), implementation of ARTs-ICSI with or without preceding testicular sperm aspiration-resulted in successful conception and childbirth. Evidence for a plausible link to male gonadal development and function has been reported for MAZ and KCTD13 at 16p11.2, and LZTR1 at 22q11.21. As an additional finding, a novel ∼3.8 Mb microduplication at 3p25.1 was identified in an oligozoospermia patient and his azoospermic son, conceived naturally at the age of 28 years. This region encompasses a triplosensitive gene, NR2C2, linked to affected meiosis and oligozoospermia in mouse models. LIMITATIONS, REASONS FOR CAUTION: WES may not detect all structural variations, such as inversions or balanced translocations. As some MMS CNVs were only identified in singleton cases (8p23.1 duplication, 2q13-14.1 and 15q13.2-13.3 deletions), the link to male infertility could not be clarified. Further data are needed about the novel large 3p25.1 microduplication to understand its effect on spermatogenesis. WIDER IMPLICATIONS OF THE FINDINGS: The yield of identified MMS in idiopathic cases with low sperm counts (∼2%) was close to the carriership of Y-chromosome microdeletions, tested in routine infertility workup. Early identification of MMS can inform genetic counselling regarding congenital health risks to the patient and future offspring and options for decision-making in ART. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Estonian Research Council (Grant number PRG1021 to M.L.). The authors declare that they have no conflict of interest in relation to the data in this paper. TRIAL REGISTRATION NUMBER: N/A.
引用
- Kikas T, Dutta A, Inno R, et al. Microdeletion and microduplication syndromes, including recurrent rearrangements at 16p11.2 and 22q11.21, are enriched in unexplained male infertility. Hum Reprod. 2026. PMID: 41338233. doi:10.1093/humrep/deaf231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。